(Q37085249)

English

Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists

scientific article published on March 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

1 reference

Europe PubMed Central

Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

literature search

1 reference

based on heuristic

inferred from title

ankylosing spondylitis

1 reference

based on heuristic

inferred from title

8

object named as

T K Kvien

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Jérôme Avouac

4

object named as

J Avouac

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

author name string

P I Sidiropoulos

1

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

G Hatemi

2

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

I-H Song

3

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

E Collantes

5

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

V Hamuryudan

6

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

M Herold

7

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

H Mielants

9

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

J M Mendoza

10

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

I Olivieri

11

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

M Østergaard

12

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

L Schachna

13

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

J Sieper

14

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

D T Boumpas

15

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

M Dougados

16

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

publication date

1 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

355-361

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromsø, northern Norway

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

ASAS/EULAR recommendations for the management of ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Clinical guidelines: developing guidelines

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Performance of referral recommendations in patients with chronic back pain and suspected axial spondyloarthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Striking Prevalence of Ankylosing Spondylitis in “Healthy” W27 Positive Males and Females

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Natural course and prognosis of HLA-B27-positive oligoarthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

The role of HLA B27 in the diagnosis and management of low-back pain and sciatica

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Rheumatic iritis and iridocyclitis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Evaluation of patients with back pain of suspected inflammatory nature

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Studying patients with inflammatory back pain and arthritis of the lower limbs clinically and by magnetic resonance imaging: many, but not all patients with sacroiliitis have spondyloarthropathy.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Assessment of disability with the World Health Organisation Disability Assessment Schedule II in patients with ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Withdrawal from labour force due to work disability in patients with ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Treatment of active ankylosing spondylitis with pamidronate

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Treatment of ankylosing spondylitis with pamidronate: an open label study

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

An open study of pulse pamidronate treatment in severe ankylosing spondylitis, and its effect on biochemical markers of bone turnover

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Sulfasalazine in ankylosing spondylitis: a prospective, randomized, double-blind placebo-controlled study and comparison with other controlled studies

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Clinical investigation of methotrexate in the treatment of ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Efficacy of cyclo-oxygenase-2 inhibition by etoricoxib and naproxen on the axial manifestations of ankylosing spondylitis in the presence of peripheral arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Pharmacological treatment of ankylosing spondylitis: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Isoxicam vs ketoprofen in ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Sulindac and indomethacin in the treatment of ankylosing spondylitis: a double-blind cross-over study

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Oxaprozin versus diclofenac sodium in the treatment of ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Treatment of ankylosing spondylitis with flurbiprofen or phenylbutazone

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Double-bind cross-over tiral of flurbiprofen and phenylbutazone in ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

A trial of feprazone in ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Relapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

How to diagnose axial spondyloarthritis early

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Risk of cardiovascular events and rofecoxib: cumulative meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEM348

21 January 2018

Identifiers

10.1093/RHEUMATOLOGY/KEM348

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37085249&oldid=2094005766"